Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: A randomized self-controlled trial and an open trial

British Journal of Dermatology

Volumn 149, Issue 2, 2003, Pages 370-376

  Holick, Michael F ^a   Chimeh, F N ^a   Ray, S ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Liposome; Parathyroid hormone; Psoriasis; Psoriasis Area and Severity Index score; PTH (1 34); Randomized self controlled trial; Skin

Indexed keywords

CALCIUM ION; LIPOSOME; NOVASOME A; PARATHYROID HORMONE[1-34]; PROPYLENE GLYCOL; SODIUM CHLORIDE;

ARTICLE; CALCIUM METABOLISM; CELL GROWTH; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EPIDERMIS CELL; ERYTHEMA; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPERCALCIURIA; MALE; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SKIN ABSORPTION; SKIN INDURATION; TREATMENT OUTCOME;

NON-PROGRAMMATIC;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; CALCIUM; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG CARRIERS; FEMALE; HUMANS; LIPOSOMES; MALE; MIDDLE AGED; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN ABSORPTION; TREATMENT OUTCOME;

EID: 0042413497     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05437.x     Document Type: Article

References (33)

1. Strewler GJ. The physiology of parathyroid hormone-related protein. N Engl J Med 2000; 342: 177-85.
2. Wysolmerski JJ, Broadus AE. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein. Annu Rev Med 1994; 45: 189-200.
3. Vortkamp A, Lee K, Lanske B et al. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996; 273: 613-22.
4. Weir EC, Philbrick WM, Amling M et al. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 1996; 93: 10240-5.
5. Wysolmerski JJ, Stewart AF. The physiology of parathyroid hormone-related protein: an emerging role as a developmental factor. Annu Rev Physiol 1998; 60: 431-60.
6. Wysolmerski JJ, Philbrick WM, Dunbar ME et al. Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development 1988; 125: 1285-94.
7. Thiede MA, Rodan GA. Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Science 1998; 242: 278-80.
8. Juppner H. Receptors for parathyroid hormone and parathyroid hormone-related peptide: exploration of their biological importance. Bone 1999; 25: 87-90.
9. Li H, Seitz PK, Thomas ML et al. Widespread expression of the parathyroid hormone-related peptide and PTH/PTHrP receptor genes in intestinal epithelial cells. Lab Invest 1995; 73: 864-70.
10. Hanafin NM, Chen TC, Heinrich G et al. Cultured human fibroblasts and not cultured human keratinocytes express a PTH/PTHrP receptor mRNA. J Invest Dermatol 1995; 105: 133-7.
11. 3. Br J Dermatol 1998; 138: 944-51.
12. Danks JA, Ebeling PR. Hayman J et al. Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin. J Bone Miner Res 1989; 4: 273-8.
13. Fukayama S, Tashjian AH Jr, Davis JN, Chisholm JC. Signaling by N- and C-terminal sequences of parathyroid hormone-related protein in hippocampal neurons. Proc Natl Acad Sci USA 1995; 92: 10182-6.
14. Massfelder T, Helwig JJ, Stewart AF. Parathyroid hormone-related protein as a cardiovascular regulatory peptide. Endocrinology 1996; 137: 3151-3.
15. Maeda S, Sutliff RL, Qian J et al. Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology 1999; 140: 1815-25.
16. 2 inhibits proliferation and induces terminal differentiation of cultured human keratinocytes. J Bone Miner Res 1988; 3: S214.
17. Holick MF, Ray S, Chen TC et al. A parathyroid hormone antagonist stimulates epidermal proliferation and hair growth in mice. Proc Natl Acad Sci USA 1994; 91: 8014-16.
18. 3 and parathyroid hormone related peptide in dermatology: a new perspective. J Invest Dermatol Symp Proc 1996; 1: 1-9.
19. Henderson JE, Kremer R, Rhim JS, Goltzman D. Parathyroid hormone-like peptides increase intracellular calcium and differentiation of keratinocytes. J Cell Biol 1992; 107: 73A.
20. Kaiser SM, Laneuville P, Bernier SM et al. Enhanced growth of a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related peptide. J Biol Chem 1992; 267: 13623-8.
21. Juhlin L, Hogforsen E, Juhlin C. Parathyroid hormone related protein is localized in the granular layer of normal skin and in the dermal infiltrates of mycosis fungoides but is absent in psoriatic lesions. Acta Derm Venereol (Stockh) 1992; 72: 81-3.
22. Fleisher D, Niemiec SM, Oh CK et al. Topical delivery of growth hormone releasing peptide using liposomal systems: an in vitro study using hairless mouse skin. Life Sci 1995; 57: 1293-7.
23. 3 and its analogues in the treatment of psoriasis. Retinoids 1998; 14: 12-17.
24. 3 for the treatment of plaque psoriasis: a pilot study. Br J Dermatol 2001; 144: 500-6.
25. 3) for the treatment of psoriasis. Br J Dermatol 1996; 134: 238-46.
26. 3 analogue, 1α,24-dihydroxycholecalciferol. Br J Dermatol 1986; 115: 431-3.
27. Kim SY, Chung SI, Yoneda K, Steinert PM. Expression of transglutaminase 1 in human epidermis. J Invest Dermatol 1995; 104: 211-17.
28. Bourke JF, Berth-Jones J, Iqbal SJ, Hutchinson PE. High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris. Br J Dermatol 1993; 129: 74-6.
29. 3 analogue (MC903) in a double-blind study. Br J Dermatol 1988; 119: 223-30.
30. 3: a cell biological study. Br J Dermatol 1993; 128: 666-73.
31. 3 on the morphological and biochemical differentiation of cultured human epidermal keratinocytes grown under serum-free conditions. J Invest Dermatol 1986; 86: 709-14.
32. Foley J, Longely BJ, Wysolmerski JJ et al. PTHrP regulates epidermal differentiation in adult mice. J Invest Dermatol 1998; 111: 1122-8.
33. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-40.